Herr H, Vertosick EA, Dalbagni G, Cha EK, et al. Prospective Phase II Study to Evaluate Response to Two Induction Courses (12
intravesical instillations) of BCG Therapy for High-Risk Non-Muscle-Invasive
Bladder Cancer. Urology 2021 Jul 15. pii: S0090-4295(21)00642.
PMID: 34274387